Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability of ABP 501 and Humira in Plaque Psoriasis
NCT05073315Phase 3Completed
- Sponsor
- Amgen
- Start
- Oct 2021
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 6
01
Overview
A Phase 3 trial of adalimumab in plaque psoriasis, sponsored by Amgen. Started Oct 2021; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05073315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073315.